Kiora Pharmaceuticals (KPRX) Misses Q2 EPS by 53c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Wall St futures rise as Treasury yields cool, oil slips
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
Tweet
Share
E-mailGet Alerts KPRX Hot Sheet
Join SI Premium – FREE
Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q2 EPS of ($0.53).
For earnings history and earnings-related data on Kiora Pharmaceuticals (KPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist: 'C.H. Robinson Worldwide (CHRW) to Acquire RXO; Buying Scale While Unlocking Margin Opportunity'
- Uber to acquire ezCater for $2.3 billion in all-cash deal
- McDonald's (MCD) PT Lowered to $280 at KeyBanc
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
